Biocontrol mechanism by root-associated Bacillus amyloliquefaciens FZB42 - a review.
Chowdhury SP, Hartmann A, Gao X, Borriss R. · 2015
Read Biocontrol mechanism by root-associated Bacillus amyloliquefaciens FZB42 - a review. by Chowdhury SP, Hartmann A, Gao X, Borriss R. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4517070.txt.
Introduction
Soumitra Paul Chowdhury, Anton Hartmann, XueWen Gao, and Rainer Borriss review a root-dwelling bacterium used on crops, in Frontiers in Microbiology in 2015. The strain, called FZB42, belongs to Bacillus amyloliquefaciens and is sold as a biofertilizer and plant protector. Nearly a tenth of its genome is given to making microbe-killing compounds, so those compounds seemed the obvious weapon.
Root-zone tests complicate that story. Apart from one compound, surfactin, the weapons appear near roots only in low amounts, and the root microbe mix barely shifts when the strain arrives. Yet added FZB42 partly undoes community changes caused by a plant pathogen. Small doses of its products seem to wake the plant's own defenses instead. The review weighs this subtler protection model.
Catalog record
| CREATOR | Chowdhury SP, Hartmann A, Gao X, Borriss R. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Biocontrol mechanism by root-associated Bacillus amyloliquefaciens FZB42 – a review By Soumitra Paul Chowdhury, Anton Hartmann, XueWen Gao, Rainer Borriss Published in: Frontiers in Microbiology DOI: 10.3389/fmicb.2015.00780 ABSTRACT Abstract Bacillus amyloliquefaciens subsp. plantarum FZB42 is a Gram-positive model bacterium for unraveling plant–microbe interactions in Bacilli. In addition, FZB42 is used commercially as biofertilizer and biocontrol agent in agriculture. Genome analysis of FZB42 revealed that nearly 10% of the FZB42 genome is devoted to synthesizing antimicrobial metabolites and their corresponding immunity genes. However, recent investigations in planta demonstrated that – except surfactin – the amount of such compounds found in vicinity of plant roots is relatively low, making doubtful a direct function in suppressing competing microflora including plant pathogens. These metabolites have been also suspected to induce changes within the rhizosphere microbial community, which might affect environment and plant health. However, sequence analysis of rhizosphere samples revealed only marginal changes in the root microbiome, suggesting that secondary metabolites are not the key factor in protecting plants from pathogenic microorganisms. On the other hand, adding FZB42 to plants compensate, at least in part, changes in the community structure caused by the pathogen, indicating an interesting mechanism of plant protection by beneficial Bacilli. Sub-lethal concentrations of cyclic lipopeptides and volatiles produced by plant-associated Bacilli trigger pathways of induced systemic resistance (ISR), which protect plants against attacks of pathogenic microbes, viruses, and nematodes. Stimulation of ISR by bacterial metabolites is likely the main mechanism responsible for biocontrol action of FZB42. Keywords: Bacillus amyloliquefaciens plantarum, FZB42, induced systemic resistance (ISR), non-ribosomal synthesized lipopeptides (NRPS), non-ribosomal synthesized polyketides (PKS), volatiles, plant growth promoting bacteria (PGPR) INTRODUCTION Plant rhizosphere is a highly competitive environment in which micro-organisms are abundantly present due to the availability of nutrients actively secreted by the plant root and mucilage. Some of these bacteria which are living within or in the vicinity of plant roots and supporting plant growth are generally referred as being plant-growth-promoting rhizobacteria (PGPR; Kloepper et al., 1980). In many cases their plant growth promoting activity is linked with their ability to suppress soil-borne plant pathogens (bacteria and microfungi), occurring in the competing microflora. Different mechanisms are discussed in this context. Besides production of antimicrobial (“antibiotics”), antiviral and nematicidal compounds, also stimulation of plant induced systemic resistance (ISR; Doornbos et al., 2012), and a beneficial effect on the composition of the host-plant microbiome might contribute to their suppressive effect (Erlacher et al., 2014). The aim of the present review is to describe the “state of the art” in elucidating interactions within the tripartite system consisting of beneficial bacterium, the pathogen and the plant by using Bacillus amyloliquefaciens FZB42 as a model. The aerobic-endospore-forming rhizobacteria belonging to B. amyloliquefaciens subsp. plantarum (Borriss et al., 2011) are known for enhancing yield of crop plants and for their biocontrol function directed against plant pathogens. The type strain of the subspecies, FZB42T, is commercially used as biocontrol bacterium being especially efficient against fungal and bacterial pathogens (Borriss, 2011). Its plant colonizing ability was demonstrated with a GFP-labeled FZB42 derivative on Lemna minor, Arabidopsis thaliana, maize, tomato, and lettuce using confocal laser scanning microscopy (Fan et al., 2011, 2012). Beneficial effects on plant growth and disease suppression were documented for B. amyloliquefaciens FZB42 on tomato, cucumber, cotton, tobacco, and lettuce for example (Grosch et al., 1999; Yao et al., 2006; Guel et al., 2008; Wang et al., 2009; Chowdhury et al., 2013, 2015). A comparison of the genomic sequence of FZB42 with that of the non-plant-associated B. amyloliquefaciens type strain DSM7T revealed significant differences in the genomic sequences of both strains (Rueckert et al., 2011). The strains have in common 3345 CDS residing in their core genomes; whilst 547 and 344 CDS were found to be unique in FZB42T and DSM7T, respectively. Notably, ability to synthesize non-ribosomally the antibacterial polyketides macrolactin and difficidin is an unique feature of the subspecies plantarum, whilst capability to synthesize an iturin-like antifungal lipopeptide (LP) is shared with subsp. amyloliquefaciens but not with the other members of the B. subtilis species complex (Figure 1). [Figure: Genome comparison of the type strains of Bacillus amyloliquefaciens, B. subtilis, and B. licheniformis. The whole genomes of B. amyloliquefaciens plantarum SQR-9 (outside circle), B. amyloliquefaciens amyloliquefaciens DSM7T (second circle), B. subtilis subtilis 168T (third circle), and B. licheniformis DSM13T (inner circle) were aligned with FZB42T using the RAST server (Aziz et al., 2008). The color code indicates % similarity of single gene products. The gene clusters responsible for non-ribosomal synthesis of the polyketides macrolactin and difficidin are unique in B. amyloliquefaciens subsp. plantarum. The iturin gene cluster (bacillomycin D) occurs also in B. amyloliquefaciens subsp. amyloliquefaciens.] In addition to FZB42T, the genomes of other B. amyloliquefaciens plantarum strains have become recently available (Borriss, 2013). The core-genome formed by 15 B. amyloliquefaciens plantarum genomes contains 3,151 genes, the pan-genome more than 6,000 genes, suggesting a high degree of flexibility in the genomes of such plant-associated B. amyloliquefaciens strains. Fifty-four genes were identified as being unique for subspecies plantarum and did not occur in the free-living soil bacterium B. amyloliquefaciens subsp. amyloliquefaciens, for e.g., gene clusters involved in synthesis of polyketides, and in carbon metabolism (Qiao et al., 2014). SECONDARY METABOLITES WITH BIOCONTROL FUNCTION Analysis of the whole FZB42 genome revealed an impressive capability to produce a diverse spectrum of different secondary metabolites aimed to suppress harmful microbes and nematodes living within the plant rhizosphere (Chen et al., 2007). In total, 11 gene clusters (Table 1) representing more than 9% of the genome are devoted to synthesizing antimicrobial metabolites (Chen et al., 2009a; Borriss, 2013). By contrast, the genomes of the closely related non-plant associated members of the B. subtilis species complex devote only around 5% of their capacity in synthesis of antimicrobials. [Table: Genes and gene cluster encoding for biocontrol metabolites in Bacillus amyloliquefaciens plantarum FZB42.] According to numerous in vitro studies it is widely assumed that its antifungal activity is due to non-ribosomal synthesis of the cyclic LP bacillomycin D and fengycin (Koumoutsi et al., 2004), whilst its antibacterial activity is mainly due to non-ribosomally synthesized polyketides (Chen et al., 2006), and bacilysin (Chen et al., 2009b), and ribosomally synthesized bacteriocins (Scholz et al., 2011, 2014). LIPOPEPTIDES DIRECT ANTIFUNGAL ACTIVITY Lipopeptides are non-ribosomally synthesized by peptide synthetases (NRPS). NRPS are giant enzymes composed of modules that house repeated sets of functional domains, which select, activate, and couple amino acids drawn from a pool of nearly 500 potential building blocks (Walsh et al., 2013). Five gene cluster involved in non-ribosomal synthesis of cyclic LP and the iron-siderophore bacillibactin were identified in the genome of FZB42 (Table 1). Three of the respective gene clusters were assigned for synthesis of surfactin, fengycin, and bacillomycin D. Bacillomycin D was identified as being the most powerful antifungal metabolite in vitro produced by FZB42 (Figure 2). The heptapeptide moiety of bacillomycin D, belonging to the iturin family of cyclic LP, is attached to a β-amino fatty acid chain of variable length (C14–C17). The peptide moiety of the heptapeptide surfactin is linked to a β-hydroxyl fatty acid (C12–C16), whilst the fengycin decapeptides are linked to a β–hydroxyl fatty acid chain (C 14–C18). Their synthesis is accomplished by multimodular peptide synthetases and